Overview
- Includes supplementary material: sn.pub/extras
Part of the book series: Contributions to Management Science (MANAGEMENT SC.)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (5 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
Research and development of novel medicines for human therapy commonly takes over a decade before significant revenues from sales are forthcoming. How can biotechnology companies be founded and grow successfully in an industry with such extended innovation processes? The book investigates this problem and distinguishes three growth phases: From incorporation and start-up through collaborative R&D with large pharmaceutical firms to value creation from R&D pipelines to Public Offerings and product marketing. In this book a dynamic simulation model for testing different decision-making strategies is developed. For each phase the author identifies decision rules that provide for successful corporate growth.
Authors and Affiliations
Bibliographic Information
Book Title: Entrepreneurship in Biotechnology
Book Subtitle: Managing for Growth from Start-Up to Initial Public Offering
Authors: Martin Grossmann
Series Title: Contributions to Management Science
DOI: https://doi.org/10.1007/978-3-642-57432-0
Publisher: Physica Heidelberg
-
eBook Packages: Springer Book Archive
Copyright Information: Springer-Verlag Berlin Heidelberg 2003
Softcover ISBN: 978-3-7908-0033-3Published: 11 March 2003
eBook ISBN: 978-3-642-57432-0Published: 06 December 2012
Series ISSN: 1431-1941
Series E-ISSN: 2197-716X
Edition Number: 1
Number of Pages: XVI, 323
Topics: Biotechnology, Innovation/Technology Management, Entrepreneurship, Pharmacology/Toxicology